Answers are grounded in this paper and cite their sources.
Hepatocellular carcinoma (HCC) lacks precise and noninvasive diagnostic tools. To address this a new positron emission tomography (PET) radiotracer, [68Ga]Ga-XH-06, was developed. It uses an antibody fragment to target glypican-3 (GPC3), a highly specific biomarker, successfully visualizing GPC3 expressions in patients with HCC, potentially meeting the important unmet need.
No takes yet. Share an insight, caveat, or question.
Seo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: